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Abstract
Background: We conducted an ancillary study among individuals who had participated in a cluster-randomized
PCV-7 trial in rural Gambia (some clusters were wholly-vaccinated while in others only young children had been
vaccinated), to determine the prevalence and risk factors for Staphylococcus aureus nasopharyngeal carriage.
Methods: Two hundred thirty-two children aged 5–10 years were recruited and followed from 4 to 20 months
after vaccination started. We collected 1264 nasopharyngeal swabs (NPS). S. aureus was isolated following
conventional microbiological methods. Risk factors for carriage were assessed by logistic regression.
Results: Prevalence of S. aureus carriage was 25.9%. In the univariable analysis, prevalence of S. aureus carriage was
higher among children living in villages wholly-vaccinated with PCV-7 [OR = 1.57 95%CI (1.14 to 2.15)] and children
with least 1 year of education [OR = 1.44 95%CI (1.07 to 1.92)]. S. aureus carriage was also higher during the rainy
season [OR = 1.59 95%CI (1.20 to 2.11)]. Carriage of S. pneumoniae did not have any effect on S. aureus carriage for
any pneumococcal, vaccine-type (VT) or non-vaccine-type (NVT) carriage. Multivariate analysis showed that the
higher prevalence of S. aureus observed among children living in villages wholly-vaccinated with PCV-7 occurred
only during the rainy season OR 2.72 95%CI (1.61–4.60) and not in the dry season OR 1.28 95%CI (0.78–2.09).
Conclusions: Prevalence of nasopharyngeal carriage of S. aureus among Gambian children increased during the
rainy season among those children living in PCV-7 wholly vaccinated communities. However, carriage of S. aureus is
not associated with carriage of S. pneumoniae.
Trial registration: ISRCTN51695599. Registered August 04th 2006.
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Background
Staphylococcus aureus is one of the most common bacteria
associated with neonatal sepsis [1–3] and child pneumonia
[4, 5] in sub-Saharan Africa. It is also a leading cause of
community and hospital-based skin and soft tissue infec-
tions [6]. S. aureus is a common colonizer of the upper
respiratory tract [7]. This asymptomatic colonization is a
necessary step on the pathway to disease [8] with
nasopharyngeal carriage [9], nasal and rectal carriage [10]
being linked to subsequent S. aureus disease.
Asymptomatic carriage of S. aureus varies extensively
between populations, age groups, gender, vaccination with
pneumococcal vaccines, socioeconomic factors and may
also show seasonal variation. In the USA, Taiwan, Mexico,
and Gabon nasopharyngeal carriage rates in the general
populations among participants age 1–90 years were re-
ported to be 30.4%, 24.1%, 37.1% and 29.0% respectively
[11–14]. In Cape Verde, prevalence of nasal carriage of S.
aureus was reported to be higher among hospitalized indi-
viduals and health care workers than in the general popu-
lation [15]. Nasopharyngeal carriage was also found to be
elevated in an urban setting [16] and among HIV infected
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individuals [17]. In The Gambia, prevalence of S. aureus
nasopharyngeal carriage was highest at birth and de-
creased during the first few weeks of life [18], although
prevalence remains high during infancy [19].
The introduction of pneumococcal conjugate vaccines
(PCVs) alters the microbial flora in the nasopharynx [20, 21]
with a substantial decrease of pneumococcal serotypes
included in the vaccine (vaccine types or VT) [22], and an
increase in other pneumococcal serotypes (non-vaccine
types or NVT) [23–25]. Among PCV naive population,
several studies have shown that colonization with S. aureus
is inversely associated with Streptococcus pneumoniae
colonization [19, 26–30]. In addition, in one study, S. aureus
carriage increased post pneumococcal vaccination with the
highest differences between vaccinated and non-vaccinated
children being found at the age of 12 months [31]. Although
the inverse association between colonization with these two
bacteria has been reported worldwide, the exact mechanism
is yet to be understood. Some reports showed that produc-
tion of hydrogen peroxide by the pneumococcus is directly
bactericidal to S. aureus [32] and the presence of the
pneumococcal pilus directly induce a host immune response
that is deleterious to S. aureus colonization [33]. Lebon and
colleagues [34] could not explain this inverse association be-
tween S. aureus and S. pneumoniae by measuring anti-
pneumococcal antibodies with S. aureus colonizing and
anti-staphylococcal antibodies with S. pneumoniae coloniz-
ing among healthy children.
Many of the studies showing the inverse association be-
tween these two bacteria are either small or the statistical
analysis does not adjust for potential confounders. In a re-
cent report from The Gambia, we showed that the inverse
association found in the crude analysis was explained by
the different carriage profile during the first year of life,
with S. aureus decreasing in prevalence from birth and S.
pneumoniae increasing, both reaching a plateau at around
20 weeks of age [35]. In this study, when age and other po-
tential confounders were considered in the adjusted ana-
lysis, there was no association between the two bacteria
with any of the S. pneumoniae endpoints analysed (overall
carriage, VT carriage and NVT carriage). A number of
other studies found no association between S. pneumoniae
and S. aureus in either carriage [35, 36] or disease [37, 38].
The aim of the analysis presented here is to assess the
prevalence and risk factors of nasopharyngeal carriage of
S. aureus among children (5–10 years of age) living in
rural Gambia who participated in a PCV-7cluster ran-
domized trial.
Methods
Trial design
The analysis presented here is ancillary to a large, single-
blinded, cluster-randomized (by village), placebo-controlled
trial of PCV-7 conducted to assess the impact of
vaccination on pneumococcal nasopharyngeal carriage. De-
tails of the study design, and the overall impact of vaccin-
ation have been described previously [20, 39]. In brief, 21
villages in rural Gambia were randomized to two arms.
Three doses of PCV-7 were given to all children below
30 months of age at the start of vaccination (July 2006) and
to all those born in the study villages during the follow-up
period (until July 2008) irrespective of the trial arm because
PCV had been shown to be effective in this age group in a
previous trial conducted in the country [40]. Vaccination in
older children and adults depended on trial arm. In wholly
vaccinated communities, all inhabitants received PCV-7. In
partly vaccinated villages, the older age groups received one
dose of serogroup C Meningococcal Conjugate Vaccine.
PCV-7 vaccine was introduced in The Gambia as part of
the Expanded Programme of Immunization across the
whole country in August 2009 and replaced by PCV-13 in
June 2011 [18].
Longitudinal study
Approximately, 5441 inhabitants lived in the study vil-
lages. Six hundred and thirty-six subjects above the age
of 30 months at the start of the trial were randomly se-
lected from the 21 study villages for participation in the
longitudinal study. Selection of participants was propor-
tional to the number of subjects in each village for the
different age groups (2.5 years to less than 5 years, 5 to
less than 15 years and 15 years and above [41]). All sub-
jects aged 5–10 years who had at least one NPS col-
lected were included in the ancillary study presented
here (232 subjects). We selected this age group for two
main reasons: (i) both prevalence of S. pneumoniae and
S. aureus nasopharyngeal carriage are high and (ii) it dis-
criminates children vaccinated with PCV-7 (wholly vac-
cinated villages) versus children not vaccinated with
PCV-7 (partly vaccinated villages).
Ethical approval
Parental consent was obtained for children who partici-
pated in the original study which was approved by the
joint MRC/Gambia Government Ethics Committee and
by the ethics committee of the London School of Hy-
giene & Tropical Medicine.
Sample handling
NPS were collected monthly during the first 3–4 months of
follow-up (starting in November 2006) and then every
3 months until June 2008 [41]. Samples collection was done
as described previously [20] in accordance with a WHO
protocol [42]. The posterior wall of the nasopharynx was
swabbed using a sterile calcium alginate swab and immedi-
ately inoculated into vials containing 1 ml of skim milk-
tryptone-glucose-glycerol (STGG) transport medium. These
vials were then placed in a cold box before being transferred
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to the Medical Research Council Laboratories in Fajara (a
distance of 90 km) within 8 h of collection. The vials were
then vortexed for a minimum of 20 s before being stored at
−70 °C until tested in batches.
Laboratory methods
Frozen STGG containing NPS were initially thawed on
ice and then vortexed briefly for a minimum of 20 s.
50 μl of thawed medium was then plated on Mannitol
Salt Agar (MSA) [CM0085, Oxoid UK] plates, the inocu-
lum streaked into four quadrants in order to semi quan-
titatively determine the bacterial load before being
incubated aerobically at 37 °C for 48 h [39]. The plates
were later examined for pale to golden yellow doomed
shaped colonies 1-2 mm in diameter. A catalase test was
performed on all suspected colonies. Catalase positive
colonies were tested further using the Staphaurex® plus
kit [OXR30950201, Oxoid UK], a rapid latex agglutin-
ation test for the identification of S. aureus. Positive iso-
lates were confirmed S. aureus.
Data management and statistical analysis
The primary aim of this analysis was to assess the preva-
lence of nasopharyngeal carriage of S. aureus and deter-
mine risk factors in the study population. The rainy
season was defined as the period from June to October
and the dry season from November to May.
Firstly, summary statistics [median and IQR for the
quantitative variables and (n%) for categorical variables]
were estimated within each variable group. The distribu-
tions of these variables were compared between groups
(S. aureus carriers versus non-carriers) using the Wil-
coxon rank-sum test or Chi-square/Fisher’s exact test.
Further, logistic regression analysis with subject as a
random effect was applied to quantify the association of
S. aureus carriage with all the co-variables, reporting
odds ratios (OR) and their 95% confidence intervals
(95%CI) while adjusting for potential confounders. Co-
variables that showed association with S. aureus carriage
in the univariate analysis (p-value ≤0.05 were included in
the multivariate analysis. Several plausible interaction
terms were tested in the multivariable analysis using
likelihood ratio tests at α = 0.050. The selection of inter-
action terms to be tested was exploratory.
A multilevel, random intercept, logistic regression
modelling technique was applied to account for the cor-
relations of samples collected from the same subject
over time and the clustering of subjects within the same
village. However, likelihood ratio tests (though conserva-
tive) showed little evidence (P-value >0.1) of within vil-
lage clustering of subjects. Hence the random intercept
models were simplified by ignoring the within village
clustering of subjects. There was little evidence of an
autocorrelation structure and an equal (independent)
correlation structure was assumed. Furthermore, robust
variance estimator were tested, but gave very similar re-
sults to the model based standard errors.
All the analyses were conducted in Stata 12.1 (Sta-
taCorp. Texas, USA). Figures were done in R statis-
tical programming software (R Core Team 2014). P-
values <0.05 have been taken to indicate statistical
significance.
Results
A total of 232 children [median age 5.7 years (range 5–
10)] took part in the study, with 131 (56.5%) of the par-
ticipants being residents in the PCV-7 wholly vaccinated
Table 1 Baseline characteristics of the study participants
Variables N %
N 232 -
Sex
Male 123 53.0
Female 109 47.0
Median age (Range) 5.7 (5–10 yrs) -
Samples collected per child Median (Range) 6.0 (1–10) -
Overall carriage 232 25.9
Missing data 11 0.01
Group
Wholly vaccinated 131 56.5
Partially vaccinated 101 43.5
Ethnicity
Jola 165 71.1
Fula 11 4.7
Mandinka 46 19.8
Other 10 4.3
Attended school
Yes 141 60.8
No 91 39.2
Smoker in house hold
Yes 104 44.8
No 128 55.2
Education
None 86 37.1
< 1 yr 42 18.1
> =1 104 44.8
Ability to read
Yes 74 31.9
No 158 68.1
Ability to write
Yes 61 26.3
No 171 73.7
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villages. One hundred and twenty three participants
(53.0%) were male; Jolas were the most common ethnic
group (71.1%). Overall, we collected 1264 NPS
[median = 6 per participant; range 1–10]. Demographic
and epidemiological characteristics of the study partici-
pants are shown in Table 1.
Table 2 Univariable analysis for association of S. aureus carriage with covariables
Variables S. aureus + % S. aureus − % Total OR 95% CI
n n
N 347 27.5 917 72.5 1264
Age (years) 1.05 0.96, 1.15
Sex
Male 194 29.5 464 70.5 658
Female 153 25.3 453 74.7 606 0.81 0.59, 1.11
Group
Partially vaccinated 221 30.9 495 69.1 716
Wholly vaccinated 126 23.0 422 77.0 548 1.57 1.14, 2.15
Ethnicity
Jola 229 26.2 646 73.8 875
Fula 17 33.3 34 66.7 51 1.42 0.67, 3.02
Mandinka 81 29.2 196 70.8 277 1.15 0.78, 1.69
Other 20 32.8 41 67.2 61 1.51 0.74, 3.10
Attended school
Student 266 28.3 673 71.7 939
Non-student 81 23.3 244 76.7 325 0.83 0.60, 1.16
Smoker in household
No 189 28.0 487 72.0 676
Yes 158 26.9 430 73.1 588 1.01 0.76, 1.34
Education
< 1 yr 120 23.8 384 76.2 504
> =1 yr 227 29.9 533 70.1 760 1.42 1.06, 1.91
Ability to read
No 160 24.7 488 75.3 648
Yes 187 30.4 429 69.6 616 1.32 1.00, 1.74
Ability to write
No 198 25.6 574 74.4 952
Yes 149 30.3 343 69.7 492 1.25 0.93, 1.68
Season
Dry 221 24.8 669 75.2 890
Rainy 126 33.7 248 66.3 374 1.59 1.20, 2.11
Any pneumococci
No 129 30.4 296 69.6 425
Yes 218 26.0 621 74.0 839 0.81 0.61, 1.07
Vaccine type (VT)
No 311 27.3 829 72.7 1140
Yes 36 29.0 88 71.0 124 1.10 0.71, 1.72
Non-vaccine type (NVT)
No 156 29.9 366 70.1 522
Yes 191 25.7 551 74.3 742 0.81 0.62, 1.07
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Prevalence of S. aureus nasopharyngeal carriage was
25.9% in the study population. In the crude analysis,
prevalence of S. aureus nasopharyngeal carriage was simi-
lar between genders and age groups (Table 2). Higher
prevalence of S. aureus carriage was found among chil-
dren from villages wholly vaccinated with PCV-7 [30.9%
vs. 23.0% OR 1.57 95%CI (1.14 to 2.15)] and children who
had attended school for at least 1 year [29.9% vs. 23.8%
OR 1.42 95%CI (1.06 to 1.91)]. In addition, prevalence of
S. aureus nasopharyngeal carriage was higher during the
rainy season compared to the dry season [33.7% vs. 24.8%
OR 1.59 95%CI (1.20 to 2.11)]. Prevalence of S. aureus car-
riage was similar between children who were carriers or
non-carriers of S. pneumoniae (either for any pneumococ-
cal carriage, VT carriage or NVT carriage) (Table 2).
The multivariate analysis (including the analysis for in-
teractions) showed that the higher prevalence of S. aureus
nasopharyngeal carriage among children from PCV-7
wholly vaccinated compared to PCV-7 partially vaccinated
communities only occurred during the rainy season [OR
2.72 95%CI (1.61 to 4.60)] and not in the dry season
[OR:1.19 (0.82, 1.71)] (Fig. 1) (Table 3).
Discussion
This paper reports the prevalence of S. aureus
nasopharyngeal carriage within the context of a PCV-7
cluster-randomized-trial in sub-Saharan Africa. Rural
communities in The Gambia were randomized to higher
or lower PCV-7 pressure (wholly versus partially vacci-
nated communities). Our findings support those of pre-
vious studies conducted in the country which showed
that S. aureus carriage among children is high and not
associated with S. pneumoniae carriage [35]. Nonethe-
less, in this study prevalence of S. aureus carriage was
higher among children from communities with the
highest PCV-7 pressure (wholly vaccinated communi-
ties) during the rainy but not the dry season.
Our results show that 25.9% of the Gambian children
included in the study were carriers of S. aureus at any
time point during the follow up period. It is difficult to
make any valid comparison between this and other stud-
ies in the country since they differ either in the labora-
tory methods used, age, setting or exposure to PCV. In a
similar study in the same setting among infants not ex-
posed to PCV, prevalence of carriage was 30.9% [35]. In
another study conducted in peri-urban Gambia among
infants exposed to PCV-7, nasopharyngeal carriage of S.
aureus was 33.6% whereas oropharyngeal carriage was
65.0% [43]. In Nigeria, S. aureus nasopharyngeal carriage
among students aged 9–32 years attending various edu-
cational establishments was 56.4% [44].
Our study revealed that despite the introduction of
PCV-7, no association between S. aureus and S. pneu-
moniae nasopharyngeal carriage was observed for any
of the S. pneumoniae end points. These results are in
line with previous data in the same villages before
PCV introduction which showed no association be-
tween these two bacteria among infants [35]. Our
trial had previously showed a strong herd effect of
PCV-7 introduction in communities partly vaccinated
with PCV-7 [20, 45] which turned into similar
pneumococcal serotype distribution in the two trial
arms. Therefore, the reasons for higher prevalence of
S. aureus in PCV-7 wholly vaccinated communities
during the rainy season are unclear. One possible ex-
planation would be that risk factors of S. aureus car-
riage differ between study arms, and thus prevalence
of carriage was already different between trial arms
before PCV-7 introduction. However, this is unlikely
due to the nature of the trial where clusters were
Fig. 1 Bi-monthly prevalence of S. aureus
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randomly selected. It could also be a chance finding
and we note that a number of variables were studied
without a prior hypothesis. Further studies will be
needed to explain these findings.
In our analysis, carriage of S. aureus follows a seasonal
pattern which peaks during the rainy season unlike S.
pneumoniae which peaks in the dry season [41]. In line
with this seasonality of carriage, Chan and colleagues
[46, 47] reported increased maternal S. aureus colonization
(RR = 1.96, 95% CI 1.29 to 2.95) during the rainy season in
Bangladesh and a study in Australia also reported an
increase of S. aureus infection during the rainy season [48].
In our setting, infections with respiratory viruses such as
RSV, influenza A, influenza B or adenoviruses are higher
during the rainy season when humidity increases [49].
Initial colonization with respiratory viruses or decreased
immune competence due to poor diet during the rainy
season may have resulted in the increased transmission of
S. aureus [50, 51]. However, we did not assess either viral
infection or diet in study participants.
Our study was limited by a number of factors related to
the design. First, we limited this ancillary analysis to
children 5–10 years of age for two main reasons. Bacterial
transmission among children tends to be higher than in
adults. Also, in this age group children had only received
PCV-7 if they live in the fully vaccinated villages which is
not the case among younger children. On the other hand,
our results on seasonality are based in a short time period.
A longer follow up would have been more robust in
establishing a seasonal pattern. The study only collected
NPS for the detection S. aureus. Although prevalence of
carriage would have likely been higher if the samples
collected were oropharyngeal swabs, we do not expect
different associations in the risk factors analysis.
Conclusion
Our findings show that transmission of S. aureus in our
setting is high which may explain the high burden of
associated disease [49]. In addition, we did not find
any association between S. aureus and S. pneumoniae
nasopharyngeal carriage. The effect of PCV introduction
on S. aureus transmission in rural Gambia will need to be
further studied after the recent introduction of PCV-13
as part of the Expanded Programme of Immunization to
determine if our findings are confirmed.
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